Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis.
Alexander Yuk-Lun LauW K IpCheryl AuK K LauWinnie WongK K YipJonas YeungS H LiPatrick LiRyan LeeDeyond SiuJill AbrigoAdrian WongVincent MokEric ChanPublished in: Multiple sclerosis journal - experimental, translational and clinical (2017)
Neutralising antibodies are associated with poor clinical outcome in Chinese patients with relapsing MS. MxA gene expression and protein induction assays are complimentary assays for neutralising antibody detection.